OncologyCell & gene therapyRare diseaseVaccines
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyCell & gene therapyRare disease
NMPAFDA
SCALE 190 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView Oncology
FDAEMAPMDANMPA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView E
Guildford, United Kingdom · Europe
OncologyRare disease
FDAEMAMHRA
SCALE 260 studies
Open to sponsorsAdvanced-therapy activeView OncologyCell & gene therapy
NMPAFDAEMAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView PC
Zug, Switzerland · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView London, United Kingdom · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 230 studies
Open to sponsorsSelectiveView Oncology
EMAFDAMHRA
SCALE 240 studies
Open to sponsorsSelectiveView Oncology
FDANMPA
SCALE 220 studies
Open to sponsorsSelectiveView Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 20 studies
Open to sponsorsGeneral clinicalView Nottingham, United Kingdom · Europe
SCALE 30 studies
Open to sponsorsGeneral clinicalView Nijmegen, Netherlands · Europe
SCALE 20 studies
Open to sponsorsGeneral clinicalView